SCHEMBL6277239

SCHEMBL6277239

COc1ccc(OCCOS(C)(=O)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
APLNR P35414 1/20 0.49
ALDH1A1 P00352 1/20 0.47
MAPT P10636 3/20 0.47
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
PKM P14618 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
ATM Q13315 1/20 0.44
APP P05067 2/20 0.43
MEN1 O00255 1/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17501637 0.91 MAPT (0.50) L3MBTL1APLNRALDH1A1MAPTMTNR1A
SCHEMBL24041775 0.84 APLNR (0.50) APLNRALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL11445546 0.83 CYP1A2 (0.50) L3MBTL1ALDH1A1SMN1; SMN2TSHRNPC1
SCHEMBL9451340 0.83 CA1 (0.55) L3MBTL1ALDH1A1MAPTMTNR1AMTNR1B
SCHEMBL6271706 0.83 MEN1 (0.46) L3MBTL1ALDH1A1MAPTLMNAKMT2A
SCHEMBL4469836 0.83 APP (0.42) ALDH1A1MAPTLMNATSHRNPC1
SCHEMBL3947128 0.83 LTA4H (0.50) L3MBTL1ALDH1A1MAPTPKMKMT2A
SCHEMBL16964735 0.83 CA12 (0.47) ALDH1A1LMNATSHRHTTKMT2A
SCHEMBL1751861 0.83 KDM4E (0.45) ALDH1A1MAPTSMN1; SMN2LMNATSHR
SCHEMBL7976554 0.82 KCNA3 (0.52) L3MBTL1ALDH1A1MAPTMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226073-A9 TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS OLEMA PHARMACEUTICALS, INC. 2024-07-11 US disclosed
US-11672785-B2 Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs OLEMA PHARMACEUTICALS, INC. (US) 2023-06-13 US disclosed
US-20050288316-A1 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists BIOVITRUM AB (SE) 2005-12-29 US disclosed
WO-2005048916-A2 TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS BIOVITRUM AB (SE) 2005-06-02 WO disclosed
US-5212316-A Respiratory system disorders BOEHRINGER MANNHEIM ITALIA (IT) 1993-05-18 US disclosed
EP-0303227-B1 ETHERS AND THIOETHERS HAVING THERAPEUTICAL ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1992-02-05 EP disclosed
US-4968706-A MUCOLYTIC, ANTITUSSIVE, BRONCHODILATOR, ANTIINFLAMMATORY BOEHRINGER MANNHEIN ITALIA, S.P.A. (IT) 1990-11-06 US disclosed
EP-0303227-A1 Ethers and thioethers having therapeutical activity, their preparation and pharmaceutical compositions containing them BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1989-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288316-A1 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists GHSR, GHRHR, PRLHR L3MBTL1 511/4885APLNR 298/4885ALDH1A1 1919/4885
US-11672785-B2 Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs ESR1, CYP19A1, HSD17B11 L3MBTL1 4621/4885APLNR 3358/4885ALDH1A1 1842/4885
US-20240226073-A9 TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS ESR1, CYP19A1, HSD17B11 L3MBTL1 4621/4885APLNR 3358/4885ALDH1A1 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.